TS
Tsumura & Co.
TSMRF · OTC
$23.20 +0.00% (+$0.00)
Market Cap ¥272.2B
P/E Ratio 8.98x
Div. Yield 4.12%
ROE 9.72%
Bulios Fair Price
$13.54
41.6% downside
Trenutna cena
$23.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TSMRF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
99 /100
Cheap P/S 1.36x
P/E 8.98x
P/B 0.84x
Growth
82 /100
Growing Book val. growth 8.70%
EPS growth 20.65%
Rev. growth 11.44%
Profitability
59 /100
Moderate Op. margin 17.77%
Gross margin 46.99%
FCF margin 9.35%
Quality
35 /100
Average ROA 5.07%
ROIC 4.81%
Asset turnover 0.33x
Debt
89 /100
Low Int. coverage 28.85x
Debt/Equity 0.45x
Net debt/EBITDA 1.26x
Stability
53 /100
Moderate EPS volatility 57.55%
Beta 0.07x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TSMRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Terukazu Kato
Employees
4,923
Headquarters
Tokyo
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
09 NOV.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila